Does Monsanto’s Roundup weedkiller need a cancer warning?

The Excerpt explores the Supreme Court's ongoing review of a landmark case involving Monsanto's Roundup weedkiller and its potential link to cancer. At the heart of the case is John Durnell, a St. Louis neighborhood volunteer known as the 'spray guy,' who developed non-Hodgkin’s lymphoma after years of using Roundup to maintain public spaces. He sued Monsanto, arguing that the company should have warned consumers about glyphosate’s possible carcinogenicity. The central legal question is whether federal preemption—specifically, the EPA’s failure to require a cancer warning label—bars state court lawsuits like Durnell’s. The justices heard arguments on Monday, with Justice Brett Kavanaugh expressing skepticism about state-level lawsuits undermining national regulatory uniformity, while Chief Justice Roberts suggested states might play a vital role in addressing gaps between EPA approval and new scientific evidence. The Trump administration supports Monsanto, pushing for domestic production of glyphosate and liability protections, while the Biden administration previously allowed such lawsuits to proceed. With tens of thousands of similar claims pending and a $7.25 billion proposed settlement in the works, the outcome could reshape agricultural practices, corporate liability, and consumer safety standards. The Court is expected to rule by late June or early July 2026.